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INTRODUCTION
Microcalcified or non-palpable breast lesions represent 6- 
35% of beast malignancies [1,2]. However, it is difficult to tar-
get the exact site of a microcalcification or non-palpable breast 
lesion if it is not detectable by ultrasound. Because stereotactic 
vacuum-assisted breast biopsy (VAB) has a higher accuracy 
rate using a horizontal (x), vertical (y), and depth (z)-axis com-
pared with ultrasound-guided VAB for breast microcalcifica-
tion or non-palpable lesions, it has been used as a reliable tech-
nique to localize and sample those breast lesions [3,4]. Further-
more, if the targeting is successful, it is easier than ultrasound-
guided VAB or surgical biopsy.
Stereotactic VAB is usually performed in a prone or upright 
position. However, an expensive, dedicated prone table is nec-
essary to perform prone-positioned stereotactic VAB. Addi-
tionally, there are some limitations to upright stereotactic VAB, 
such as inconvenience or a vasovagal reaction of patients [2,5,6]. 
Although the lateral decubitus position is an alternative posi-
tion for stereotactic VAB, the breast lesion often moves in the 
lateral decubitus position, as identified in cranio-caudal (CC) 
or mediolateral-oblique (MLO) mammography views [7]. There-
fore, a true lateral mammography view is needed to overcome 
this problem, which is nearly identical to stereotactic mammog-
raphy in a lateral decubitus position.
We used the lateral decubitus position during stereotactic 
VAB combined with true lateral mammography on 15 patients. 
CASE REPORT
Between January and June 2010, we performed stereotactic 
directional VAB on 15 patients at the Breast Cancer Center of 
Pusan National University Hospital. In all cases, the CC and 
MLO mammography planes were preferentially reviewed to 
identify non-palpable lesions with or without microcalcifica-
tions, and those lesions were classified according to the Breast 
Imaging Reporting and Data System (BI-RADS). True lateral 
views of the mammographic images (GE Medical Systems, 
Milwaukee, USA) were obtained in all cases before lateral de-
cubitus positioning for stereotactic VAB. 
The patient laid on a stereotactic VAB table (Digital Stereo-
taxy with Senographe DS Interventional; GE Medical Systems) 
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Stereotactic vacuum-assisted breast biopsy (VAB) has been 
used to evaluate microcalcifications or non-palpable breast le-
sions on mammography. Although stereotactic VAB is usually 
performed in a prone or upright position, an expensive prone ta-
ble is necessary and vasovagal reactions often occur during the 
procedure. For these reasons, the lateral decubitus position can 
be applied for stereotactic VAB, and true lateral mammography 
can be used to detect the lesion. We report on 15 cases of later-
al decubitus positioning for stereotactic VAB with true lateral 
mammography for non-palpable breast lesions or microcalcifi-
cations. The mean procedure time was approximately 30.1 min-
utes, and no complications occurred during the procedures. Four-
teen cases had benign breast lesions and one case had a ductal 
carcinoma in situ. The lateral decubitus stereotactic VAB with true 
lateral mammography can be applied for microcalcifications or 
non-palpable breast lesions and helps to minimize anxiety and 
vasovagal reactions in patients.
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in the lateral decubitus position with the breast lesion facing 
up (Figure 1). The scout view and 15° paired stereotactic mam-
mography were performed to localize the breast lesion, which 
was compared with a true lateral view (Figure 2). We calculat-
ed the horizontal (x) and vertical (y) distanced and the depth 
(z) from the zero point of the stereotactic VAB device. Local 
anesthesia was performed with 2 mL of a 2% lidocaine injec-
tion under aseptic conditions. The incision was usually 4 mm 
according to the skin crease. Stereotactic 15° paired mammo-
graphic views were obtained again after an 8-gauge VAB probe 
(Mammotome
®; Ethicon-Endosurgery, Cincinnati, USA) was 
inserted to verify the site where the microcalcification was lo-
cated. The needle position was corrected when the distance was 
more than 2 mm between the needle tip and the breast lesion. 
Stereotactic VAB was performed by one clinical physician. 
Each of two breast tissue specimens were collected from six 
clockwise directions (2, 4, 6, 8, 10, and 12 o’clock) and arranged 
in a regular sequence on a Petri dish containing round filter 
paper (Figure 3). The stereotactic VAB was concluded when 
the breast lesion was identified by specimen mammography 
in more than two breast tissues. Additional sampling was per-
formed when the breast lesion was still identified on stereotac-
tic mammography or was not identified in specimen mam-
mography. The procedure time was determined to be from 
probe insertion to removal.
A post-procedure mammography view was obtained after a 
breast marker clip (Johnson & Johnson, Ethicon-Endosurgery, 
Cincinnati, USA) was inserted. The breast was manually com-
pressed at the procedure table. Only a piece of strip envelope 
(Steri-Strip; 3M, St. Paul, USA) and a compression bandage 
were used as a wound dressing. 
Microcalcifications were observed in 12 (80.0%) of the 15 
cases, and the remaining three cases (20.0%) showed non-pal-
pable breast masses. Eight cases (53.3%) were classified as BI-
RADS category 3 and seven (46.7%) were category 4 (Table 1). 
The morphological characters of the microcalcifications were 
Figure 1. Patient laid on the stereotactic vacuum-assisted breast biopsy 
table in the lateral decubitus position with the breast lesion upside.
Figure 2. A scout 15° paired stereotactic mammography view. The tar-
geted microcalcification is seen below the probe. 
Figure 3. Specimen mammography shows a microcalcification in three 
separate specimens (yellow circles). 
Table 1. Radiologic classification in fifteen stereotactic vacuum-assisted 
breast biopsy (VAB) cases
Characteristics Stereotactic VAB
No. (%)
Breast Imaging Reporting and Data System (BI-RADS)
   Probably benign lesion (category 3)   8 (53.3)
   Suspicious abnormality (category 4)   7 (46.7)
Mammographic findings
   Non-palpable breast lesion without microcalcification   3 (20.0)
   Non-palpable breast lesion with microcalcification 12 (80.0)66   Youn Joo Jung, et al.
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scattered punctuate (n=5), clustered punctuate (n=4), amor-
phous (n=2) and pleomorphic (n=1). Non-palpable masses 
without microcalcifications were spiculated (n=2) and oval 
shape (n=1). Microcalcification clusters were 6-15 mm in di-
ameter (mean, 10.3 mm) and masses were 6-8 mm in diame-
ter (mean, 6.7 mm) (Table 2).
The mean patient age was 45.7 years (range, 33-63). Ten cases 
of microcalcifications were identified in the first specimen mam-
mographic image, and the breast marker clip was located ac-
curately in two cases of non-palpable masses after one proce-
dure. The mean procedure time was approximately 30.1 min-
utes, and the average number and length of obtained core tis-
sues was 14.4 (range, 9-26) and 2.7 cm (range, 0.8-3.3), respec-
tively. No patient developed a vasovagal reaction such as nau-
sea, vertigo, or syncope during the procedure. One week after 
the procedure, complications were identified by a physical ex-
amination and ultrasound. A minimal hematoma was observed 
in two cases (13.3%), which resolved spontaneously (Table 3). 
In the histopathologic diagnoses of the stereotactic VAB, 14 
cases had benign breast lesions and 1 case was a ductal carci-
noma in situ (DCIS). Additional breast conserving surgery 
(quadrantectomy with a local flap) was performed for the ma-
lignant case. Among 12 cases of microcalcification on mam-
mography, the microcalcification was confirmed in 11 (91.7%) 
by the pathological findings of normal stroma, benign duct-
ules, fibrocystic changes, or DCIS. The other case of microcal-
cification on mammography revealed only benign ductules. 
Three cases without microcalcification on mammography were 
confirmed as sclerotic stroma with benign breast tissue. Fibro-
adenomas were identified in two cases, which were combined 
with fibrocystic changes and microcalcification (Table 4).   
DISCUSSION
Stereotactic breast biopsy is a reliable procedure for localiz-
ing and sampling of breast tissue using mammography. Stereo-
tactic VAB has a high sensitivity (98%) and specificity (100%) 
and may provide a promising alternative to open breast biopsy 
[1,8-12]. Among various type of stereotactic breast biopsy, ste-
reotactic VAB is indicated for microcalcifications or non-pal-
pable breast lesions not detectable by ultrasound. BI-RADS 
categories 3 or 4 for non-palpable breast lesions are usually ap-
plied for stereotactic breast biopsy, because category 5 or higher 
cases should be submitted to ultrasound-guided needle biopsy 
[13].
Stereotactic VAB is a very consistent and easy procedure if 
the needle is well located when targeting the breast lesion. Be-
cause accurate targeting is key for stereotactic VAB, the needle 
should be inserted at the exact site of the calculated x, y, and 
z-axis points from the zero point, which is set in the VAB ma-
chine. Furthermore, the complication rates for stereotactic VAB 
are relatively lower than ultrasound-guided VAB, because less 
Table 2. Characteristics of mammography in fifteen stereotactic vacu-
um-assisted breast biopsy (VAB) cases
Characteristics Stereotactic 
VAB
Diameter 
(mm)*
Feature of microcalcification
   Scattered punctuate microcalcification 5 11.8 (9-15)
   Clustered punctuate microcalcification 4 10.3 (6-13)
   Amorphous microcalcification 2 7.5 (7-8)
   Pleomorphic microcalcification 1 8.0
Feature of non-palpable mass without  
   microcalcification
   Spiculated mass alone 2 7.0 (6-8)
   Oval shape mass alone 1 6.0
*Median (range). 
Table 3. Clinical characteristics of stereotactic vacuum-assisted breast 
biopsy cases
Characteristics
Age (yr)
   Mean 45.7
   Range 33-63
No. of procedure, No. (%)
   1 12 (80.0)
   2     2 (13.30)
   3 1 (6.7)
Procedure time (total, min)
   Mean 30.1
   Range 15-50
No. of breast tissues
   Mean 14.4
   Range 9-26
Length of breast tissues (cm)
   Mean   2.7
   Range 0.8-3.3
Complication after procedure, No. (%)
   Yes (Hematoma*)   2 (13.3)
    No 13 (86.7)
*All of cases were resolved spontaneously.
Table 4. Histopathologic diagnosis in stereotactic vacuum-assisted 
breast biopsy (VAB) cases
Histopathologic diagnosis Stereotactic VAB, 
No. (%)
Benign ductules 1 (6.7)
Sclerotic stroma with benign breast tissue   3 (20.0)
Fibroadenoma with fibrocystic change and  
   microcalcification
  2 (13.3)
Microcalcification associated with stroma 1 (6.7)
Microcalcification with benign ductules   4 (26.7)
Fibrocystic change with microcalcification   3 (20.0)
Ductal carcinoma in situ with microcalcification 1 (6.7)True Lateral Mammography with Stereotactic VAB 67
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breast tissue is collected. The failure rate for stereotactic VAB 
is 3-10%, mostly due to a difficult procedure site or a compli-
cation such as a lesion near the skin, muscle or axilla [2,4]. In 
our study, we did not encounter a case in which we could not 
use stereotactic VAB, and a surgical operation was added only 
for a malignant lesion. Because no further procedures were 
performed for the other 14 benign lesions, the sensitivity and 
specificity of stereotactic VAB could not be evaluated.
A limitation of stereotactic VAB is that less breast tissue vol-
ume is obtained than with ultrasound-guided VAB. The pro-
cedure completion time for stereotactic VAB is usually not in-
dicated in studies and no definite guideline exists. We termi-
nated the procedure when microcalcifications were seen in 
more than two tissues obtained for specimen mammography 
or when the breast marker clip was accurately located at a breast 
lesion on post-procedure mammography. Because stereotactic 
VAB focuses on diagnosis and not treatment, additional pro-
cedures are unnecessary. But, the rate of atypical ductal hyper-
plasia (ADH, 20.9%) or DCIS (11.2%) can be underestimated 
[8]. Therefore, identifying an ADH or DCIS during stereotac-
tic VAB warrants a further procedure or surgical excision. 
Although stereotactic VAB is definitely an innovative diag-
nostic procedure, its disadvantages are that it is conducted in 
a prone position and that the unit is very large and expensive 
(approximately quadruple that of a regular unit). It is also dif-
ficult to perform stereotactic VAB when the targeting site is 
close to the pectoralis muscle, axilla, or skin [6,13]. In contrast, 
stereotactic VAB in an upright position allows the breast lesion 
to be easily found with a scout image, which is almost same as 
the CC plane of original mammography. However, it is very 
difficult to maintain a stable position, because transient neck 
and back pain, as well as body numbness are common during 
the procedure, especially in the elderly. Moreover, patients can 
see the sharp devices, the wound and even blood, which cause 
anxiety, emotional stress, and possibly a vasovagal reaction, 
such as nausea, vertigo, or syncope [2,3,6].  
To compensate for the disadvantages of the prone or up-
right-positioning for stereotactic VAB, a one-side decubitus 
position was used, which is more comfortable and stable for 
the patients, even if it has not been generally used [7]. An ex-
pensive prone table is unnecessary for lateral positioning dur-
ing stereotactic VAB and it causes neither a vasovagal reaction 
nor neck, or back pain. But, it is more difficult to detect the 
breast lesion, because the lesions often moves, which is differ-
ent from standard mammography. To alleviate this problem, 
we performed a true lateral mammography view before the 
procedure, which lengthened the procedure. Breast lesions 
could be easily identified on stereotactic mammography, be-
cause the targeted site was nearly the same as the pre-proce-
dure true lateral view mammography. 
Our report has limitations such as the small number of cases 
with a short term follow-up and the absence of a comparison 
between stereotactic VAB and other diagnostic procedures. 
According to several studies, 6-27% of benign breast lesions 
remain after a VAB procedure, and it is difficult to distinguish 
between a post-procedural scar and residual lesion within 6 
months [14,15]. Therefore, long term follow-up is necessary to 
evaluate for a residual breast lesion. Although this report has 
simply introduced a diagnostic procedure, the usefulness of 
lateral decubitus positioning for stereotactic VAB with true lat-
eral mammography could be verified if a comparison between 
stereotactic VAB and open biopsy or ultrasound-guided VAB 
with a long term follow-up result was added. 
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